We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Approach to Diabetes Based on Microneedle Smart Patch Insulin Delivery

By LabMedica International staff writers
Posted on 02 Feb 2017
A novel "microneedle smart patch" has been developed that was designed to automatically correct glucose imbalance in patients with type I or advanced type II diabetes.

An interdisciplinary team of investigators at North Carolina State University and the University of North Carolina designed a smart patch comprising microneedles made from block copolymer incorporated with polyethylene glycol (PEG) and phenylboronic ester (PBE)-conjugated polyserine.

The device, which integrated H2O2-responsive polymeric vesicles (PVs) with a transcutaneous microneedle-array patch, were loaded with the enzyme glucose oxidase (GOx) and insulin. More...
The microneedles functioned as both moieties of the glucose sensing element (GOx) and the insulin release actuator to provide basal insulin release as well as promote insulin release in response to hyperglycemic states.

Results reported in the current study, which was published in the January 4, 2017, online edition of the journal ACS Nano, revealed that insulin release responded quickly to elevated glucose and that its kinetics could be modulated by adjusting the concentration of GOx loaded into the microneedles. Using a mouse diabetes model, the investigators showed that a single patch could regulate glucose levels effectively with reduced risk of hypoglycemia.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
BKE-B
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.